Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes

Atherosclerosis

Volumn 227, Issue 2, 2013, Pages 425-428

  Fujisawa, Keiko ^a   Katakami, Naoto ^a   Kaneto, Hideaki ^a   Naka, Toyoko ^a   Takahara, Mitsuyoshi ^a   Sakamoto, Fumie ^a   Irie, Yoko ^a   Miyashita, Kazuyuki ^a   Kubo, Fumiyo ^a   Yasuda, Tetsuyuki ^a   Matsuoka, Taka aki ^a   Shimomura, Iichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Cardiovascular event; RAGE; SRAGE; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; SOLUBLE RAGE PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS;

AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECEPTORS, IMMUNOLOGIC; REGRESSION ANALYSIS; RISK FACTORS; TIME FACTORS;

EID: 84875052018     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.01.016     Document Type: Article

References (14)

1. Stern D.M., Yan S.D., Yan S.F., Schmidt A.M. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes. Ageing Res Rev 2002, 1:1-15.
2. Schmidt A.M., Hasu M., Popov D., et al. Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc Natl Acad Sci U S A 1994, 91:8807-8811.
3. Park L., Raman K.G., Lee K.J., et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 1998, 4:1025-1031.
4. Bucciarelli L.G., Wendt T., Qu W., et al. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation 2002, 106:2827-2835.
5. Nakamura K., Yamagishi S., Adachi H., et al. Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease. Diabetes Metab Res Rev 2007, 23:368-371.
6. Nin J.W., Jorsal A., Ferreira I., et al. Higher plasma soluble receptor for advanced glycation end products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes 2010, 59:2027-2032.
7. Colhoun H.M., Betteridge D.J., Durrington P., et al. Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial. Diabetes 2011, 60:2379-2385.
8. Cai X.Y., Lu L., Wang Y.N., et al. Association of increased S100B, S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat model with ischemia-reperfusion injury. Atherosclerosis 2011, 217:536-542.
9. Falcone C., Emanuele E., D'Angelo A., et al. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler Thromb Vasc Biol 2005, 25:1032-1037.
10. Hudson B.I., Park Moon Y., Kalea A.Z., et al. Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS). Atherosclerosis 2011, 216:192-198.
11. Lindsey J.B., Lemos J.A., Cipollone F., et al. Association between circulating soluble receptor for advanced glycation end products and atherosclerosis. Diabetes Care 2009, 32:1218-1220.
12. McNair E.D., Wells C.R., Qureshi A.M., et al. Soluble receptors for advanced glycation end products (sRAGE) as a predictor of restenosis following percutaneous coronary intervention. Clin Cardiol 2010, 33:678-685.
13. Basta G., Turco S.D., Navarra T., et al. Inverse association between circulating levels of soluble receptor for advanced glycation end-products and coronary plaque burden. J Atheroscler Thromb 2012, 19:941-948.
14. Raucci A., Cugusi S., Antonelli A., et al. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J 2008, 22:3716-3727.